James has over 30 years’ experience in the pharmaceutical and biotechnology industries
covering a wide range of therapeutic areas and development phases I to IV. Prior to joining
Levicept he was CDO at F-star Therapeutics where he was responsible for setting the
strategy and overseeing the delivery, execution and management of multiple concurrent
oncology clinical trials and broader development strategy. Prior to F-star, he held CDO roles
at Ellipses Pharma, Immunocore and Creabilis Pharmaceuticals. His earlier career was at
AstraZeneca and Pfizer in a variety of senior roles. Over his career, James has taken
several drugs to MAA/BLA filing including Celebrex for the treatment of osteoarthritis (OA)
pain.
